Journal article
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis
Abstract
BACKGROUND: High histologic remission rates have been reported with placebos in randomized controlled trials (RCTs) evaluating ulcerative colitis (UC) therapies and have varied based on trial designs. We performed a systematic review and meta-analysis to quantify placebo histological remission rates and identify factors influencing those rates.
METHODS: MEDLINE, EMBASE, and the Cochrane library were searched from inception of the databases …
Authors
Youssef M; Dong K; Lee SJ; Narula N
Journal
Inflammatory Bowel Diseases, Vol. 30, No. 1, pp. 125–131
Publisher
Oxford University Press (OUP)
Publication Date
January 5, 2024
DOI
10.1093/ibd/izad013
ISSN
1078-0998